Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy

Anna S. Lok, Robert Perrillo, Christina M. Lalama, Michael W. Fried, Steven H. Belle, Marc G. Ghany, Mandana Khalili, Robert J. Fontana, Richard K. Sterling, Norah Terrault, Jordan J. Feld, Adrian M. Di Bisceglie, Daryl T.Y. Lau, Mohamed Hassan, Harry L.A. Janssen, Hepatitis B Research Network (HBRN) – 16 September 2020

HepatoScore‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk

Jeffrey S. Morris, Manal M. Hassan, Ye Emma Zohner, Zeya Wang, Lianchun Xiao, Asif Rashid, Abedul Haque, Reham Abdel‐Wahab, Yehia I. Mohamed, Karri L. Ballard, Robert A. Wolff, Bhawana George, Liang Li, Genevera Allen, Michael Weylandt, Donghui Li, Wenyi Wang, Kanwal Raghav, James Yao, Hesham M. Amin, Ahmed Omar Kaseb – 15 September 2020

Characteristics of Patients With Chronic Hepatitis B Virus Infection With Genotype E Predominance in Burkina Faso

Nicha Wongjarupong, Albert Theophane Yonli, Bolni Marius Nagalo, Florencia Wendkuuni Djigma, Sosthene Kounpielime Somda, Mohamed A. Hassan, Essa A. Mohamed, Abel Pegdwende Sorgho, Tegwinde Rebeca Compaore, Serge Theophile Soubeiga, Isabelle Kiendrebeogo, Mahamoudou Sanou, Birama Diarra, Hwai‐I Yang, Chien‐Jen Chen, Abdoul K. Ouattara, Théodora M. Zohoncon, Jeremy J. Martinson, Kenneth Buetow, Jean Christopher Chamcheu, Samuel O. Antwi, Mitesh J. Borad, Jacques Simpore, Lewis R.

Subscribe to